J&J sets top price for consumer health unit Kenvue’s IPO

J&J sets top price for consumer health unit Kenvue’s IPO

Source: 
Pharmaphorum
snippet: 

Johnson & Johnson’s consumer health unit Kenvue looks set to raise $3.8 billion in an upsized initial public offering (IPO), valuing the business at around $41 billion and making it the biggest public listing in the US in nearly two years.